EGRX - Eagle Pharmaceuticals Inc. (EGRX) CEO Scott Tarriff on Q3 2020 Results - Earnings Call Transcript

Eagle Pharmaceuticals, Inc. (EGRX) Q3 2020 Earnings Conference Call Nov 02, 2020, 08:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - CEO Brian Cahill - CFO David Pernock - President and COO Conference Call Participants Randall Stanicky - RBC Capital Tim Lugo - William Blair Brandon Folkes - Cantor Fitzgerald Gregg Gilbert - Truist Presentation Operator Good morning, everyone. My name is Reed, and I'll be your conference operator. At this time, I'd like to welcome everyone to Eagle Pharmaceuticals' Third Quarter 2020 Earnings Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer period. [Operator Instructions] As a reminder, this conference call is being recorded today, November 2, 2020. It is now my pleasure to turn the floor over to Ms. Lisa Wilson, Investor Relations for Eagle Pharmaceuticals. Please go ahead. Lisa

For further details see:

Eagle Pharmaceuticals, Inc. (EGRX) CEO Scott Tarriff on Q3 2020 Results - Earnings Call Transcript